STOCK TITAN

[Form 4] VOLITIONRX LTD Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Positive)
Form Type
4

VolitionRx Ltd (VNRX) director Guy Archibald Innes purchased 96,153 shares of common stock on October 14, 2025 at $0.51 per share (the stock portion of a $0.52 unit price), and received warrants to buy 96,153 shares at an exercise price of $0.60 expiring October 14, 2030. The transaction occurred in connection with an underwritten public offering.

Following the transaction, he directly holds 1,062,967 common shares. Indirect positions are listed, including 1,400,000 shares by The Innes Family Bare Trust 2023 and 356,000 shares by The Dill Faulkes Educational Trust Limited, as disclosed. Additional indirect holdings include shares held for his children.

VolitionRx Ltd (VNRX) il direttore Guy Archibald Innes ha acquistato 96.153 azioni ordinarie il 14 ottobre 2025 a 0,51 dollari per azione (la parte azionaria di un prezzo unitario di 0,52 dollari) e ha ricevuto warrant per acquistare 96.153 azioni a un prezzo di esercizio di 0,60 dollari che scade il 14 ottobre 2030. La transazione è avvenuta in relazione a una offerta pubblica sottoscritta. Dopo la transazione, detiene direttamente 1.062.967 azioni ordinarie. Le posizioni indirette sono elencate, tra cui 1.400.000 azioni detenute da The Innes Family Bare Trust 2023 e 356.000 azioni da The Dill Faulkes Educational Trust Limited, come comunicato. Ulteriori detenzioni indirette includono azioni detenute per i suoi figli.
El director Guy Archibald Innes de VolitionRx Ltd (VNRX) compró 96,153 acciones ordinarias el 14 de octubre de 2025 a 0,51$ por acción (la parte de acciones de un precio unitario de 0,52$) y recibió warrants para comprar 96,153 acciones a un precio de ejercicio de 0,60$, con vencimiento el 14 de octubre de 2030. La operación se realizó en relación con una oferta pública suscrita. Después de la transacción, posee directamente 1,062,967 acciones ordinarias. Las posiciones indirectas están listadas, incluyendo 1,400,000 acciones por The Innes Family Bare Trust 2023 y 356,000 acciones por The Dill Faulkes Educational Trust Limited, como se indicó. Se incluyen también participaciones indirectas adicionales en acciones en beneficio de sus hijos.
VolitionRx Ltd (VNRX) 이사인 Guy Archibald Innes가 2025년 10월 14일 주당 0.51달러에 보통주 96,153주를 매입했고(0.52달러 단가의 주식 부분), 만료일이 2030년 10월 14일인 행사가 0.60달러인 워런트를 96,153주 매수할 수 있도록 받았습니다. 이 거래는 공모에 따른 거래이다. 거래 이후 그는 직접 1,062,967주의 보통주를 보유한다. Indirect 포지션은 The Innes Family Bare Trust 2023의 1,400,000주와 The Dill Faulkes Educational Trust Limited의 356,000주를 포함하여 공시된 바와 같이 목록에 있다. 자녀를 위해 보유한 추가 간접 보유 주식도 있다.
Le administrateur de VolitionRx Ltd (VNRX), Guy Archibald Innes, a acheté 96 153 actions ordinaires le 14 octobre 2025 à 0,51 $ par action (la part actions d’un prix unitaire de 0,52 $), et a reçu des warrants pour acheter 96 153 actions à un prix d’exercice de 0,60 $ expirant le 14 octobre 2030. La transaction a eu lieu dans le cadre d’une offre publique souscrite. Suite à la transaction, il détient directement 1 062 967 actions ordinaires. Des positions indirectes sont indiquées, notamment 1 400 000 actions par The Innes Family Bare Trust 2023 et 356 000 actions par The Dill Faulkes Educational Trust Limited, comme divulgué. Des holdings indirectes supplémentaires incluent des actions détenues pour ses enfants.
Direktor Guy Archibald Innes von VolitionRx Ltd (VNRX) hat am 14. Oktober 2025 96.153 Stammaktien zum Preis von 0,51 $ pro Aktie gekauft und Warrants zum Kauf von 96.153 Aktien zu einem Ausübungspreis von 0,60 $ erhalten, die am 14. Oktober 2030 verfallen. Die Transaktion erfolgte im Zusammenhang mit einer unterzeichneten öffentlichen Platzierung. Nach der Transaktion hält er direkt 1.062.967 Stammaktien. Indirekte Positionen sind aufgeführt, darunter 1.400.000 Aktien von The Innes Family Bare Trust 2023 und 356.000 Aktien von The Dill Faulkes Educational Trust Limited, wie angegeben. Zusätzliche indirekte Beteiligungen umfassen Aktien, die für seine Kinder gehalten werden.
مدير VolitionRx Ltd (VNRX)، غاي أرتشيبالد إينز، اشترى 96,153 سهماً عاديّاً في 14 أكتوبر 2025 بسعر 0.51 دولار للسهم، وتلقّى وِرات لشراء 96,153 سهماً بسعر ممارسة 0.60 دولار ينتهي في 14 أكتوبر 2030. تمت الصفقة في إطار عرض عام مُكتتب فيه. بعد الصفقة، يمتلك مباشرة 1,062,967 سهماً عاديّاً. وتُذكر المواقع غير المباشرة، بما في ذلك 1,400,000 سهم من The Innes Family Bare Trust 2023 و356,000 سهم من The Dill Faulkes Educational Trust Limited، كما ورد. وتشمل ملكيات غير مباشرة إضافية أسهماً مملوكاً لأطفاله.
VolitionRx Ltd (VNRX) 董事 Guy Archibald Innes 于 2025 年 10 月 14 日以每股 0.51 美元购买 96,153 股普通股(占 0.52 美元 单价中的股票部分),并获得以 0.60 美元 行权价、于 2030 年 10 月 14 日到期的认股权证,可购买 96,153 股。该交易与一次承销的公开发行相关。交易完成后,他直接持有 1,062,967 股普通股。列有间接持股,包括 The Innes Family Bare Trust 2023 的 1,400,000 股,以及 The Dill Faulkes Educational Trust Limited 的 356,000 股,如披露所示。还包括为其子女持有的其他间接持股。
Positive
  • None.
Negative
  • None.
VolitionRx Ltd (VNRX) il direttore Guy Archibald Innes ha acquistato 96.153 azioni ordinarie il 14 ottobre 2025 a 0,51 dollari per azione (la parte azionaria di un prezzo unitario di 0,52 dollari) e ha ricevuto warrant per acquistare 96.153 azioni a un prezzo di esercizio di 0,60 dollari che scade il 14 ottobre 2030. La transazione è avvenuta in relazione a una offerta pubblica sottoscritta. Dopo la transazione, detiene direttamente 1.062.967 azioni ordinarie. Le posizioni indirette sono elencate, tra cui 1.400.000 azioni detenute da The Innes Family Bare Trust 2023 e 356.000 azioni da The Dill Faulkes Educational Trust Limited, come comunicato. Ulteriori detenzioni indirette includono azioni detenute per i suoi figli.
El director Guy Archibald Innes de VolitionRx Ltd (VNRX) compró 96,153 acciones ordinarias el 14 de octubre de 2025 a 0,51$ por acción (la parte de acciones de un precio unitario de 0,52$) y recibió warrants para comprar 96,153 acciones a un precio de ejercicio de 0,60$, con vencimiento el 14 de octubre de 2030. La operación se realizó en relación con una oferta pública suscrita. Después de la transacción, posee directamente 1,062,967 acciones ordinarias. Las posiciones indirectas están listadas, incluyendo 1,400,000 acciones por The Innes Family Bare Trust 2023 y 356,000 acciones por The Dill Faulkes Educational Trust Limited, como se indicó. Se incluyen también participaciones indirectas adicionales en acciones en beneficio de sus hijos.
VolitionRx Ltd (VNRX) 이사인 Guy Archibald Innes가 2025년 10월 14일 주당 0.51달러에 보통주 96,153주를 매입했고(0.52달러 단가의 주식 부분), 만료일이 2030년 10월 14일인 행사가 0.60달러인 워런트를 96,153주 매수할 수 있도록 받았습니다. 이 거래는 공모에 따른 거래이다. 거래 이후 그는 직접 1,062,967주의 보통주를 보유한다. Indirect 포지션은 The Innes Family Bare Trust 2023의 1,400,000주와 The Dill Faulkes Educational Trust Limited의 356,000주를 포함하여 공시된 바와 같이 목록에 있다. 자녀를 위해 보유한 추가 간접 보유 주식도 있다.
Le administrateur de VolitionRx Ltd (VNRX), Guy Archibald Innes, a acheté 96 153 actions ordinaires le 14 octobre 2025 à 0,51 $ par action (la part actions d’un prix unitaire de 0,52 $), et a reçu des warrants pour acheter 96 153 actions à un prix d’exercice de 0,60 $ expirant le 14 octobre 2030. La transaction a eu lieu dans le cadre d’une offre publique souscrite. Suite à la transaction, il détient directement 1 062 967 actions ordinaires. Des positions indirectes sont indiquées, notamment 1 400 000 actions par The Innes Family Bare Trust 2023 et 356 000 actions par The Dill Faulkes Educational Trust Limited, comme divulgué. Des holdings indirectes supplémentaires incluent des actions détenues pour ses enfants.
Direktor Guy Archibald Innes von VolitionRx Ltd (VNRX) hat am 14. Oktober 2025 96.153 Stammaktien zum Preis von 0,51 $ pro Aktie gekauft und Warrants zum Kauf von 96.153 Aktien zu einem Ausübungspreis von 0,60 $ erhalten, die am 14. Oktober 2030 verfallen. Die Transaktion erfolgte im Zusammenhang mit einer unterzeichneten öffentlichen Platzierung. Nach der Transaktion hält er direkt 1.062.967 Stammaktien. Indirekte Positionen sind aufgeführt, darunter 1.400.000 Aktien von The Innes Family Bare Trust 2023 und 356.000 Aktien von The Dill Faulkes Educational Trust Limited, wie angegeben. Zusätzliche indirekte Beteiligungen umfassen Aktien, die für seine Kinder gehalten werden.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Innes Guy Archibald

(Last) (First) (Middle)
1489 WEST WARM SPRINGS ROAD
SUITE 110

(Street)
HENDERSON NV 89014

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
VOLITIONRX LTD [ VNRX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/14/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/14/2025 P 96,153(1) A $0.51 1,062,967 D
Common Stock 1,400,000 I By The Innes Family Bare Trust 2023(2)
Common Stock 356,000 I By The Dill Faulkes Educational Trust Limited(3)
Common Stock 154,503 I By son
Common Stock 154,503 I By son
Common Stock 154,504 I By daughter
Common Stock 154,504 I By daughter
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Warrant (Right to Buy) $0.6 10/14/2025 P 96,153(1) 10/14/2025 10/14/2030 Common Stock 96,153 $0.01 96,153 D
Explanation of Responses:
1. The shares of common stock and accompanying common stock warrants were purchased by the reporting person from the underwriter in connection with an underwritten public offering by the Issuer. The offering closed on October 14, 2025. The reported sale price reflects the price of $0.52 per share of common stock and accompanying warrant to purchase one additional share of common stock, of which $0.01 of the sale price was allocated to the warrant.
2. These shares of Common Stock are beneficially owned by The Innes Family Bare Trust 2023, which is a separate legal entity, of which the reporting person is the Trustee, for the benefit of his children.
3. These shares of Common Stock are beneficially owned by The Dill Faulkes Educational Trust Limited ("DFET"), a UK registered charity. The reporting person serves as a director and trustee of DFET and shares voting and dispositive control over these shares but disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
Remarks:
/s/ Guy Archibald Innes 10/15/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Volitionrx

NYSE:VNRX

VNRX Rankings

VNRX Latest News

VNRX Latest SEC Filings

VNRX Stock Data

52.42M
86.79M
17.84%
22.29%
0.28%
Medical Devices
In Vitro & in Vivo Diagnostic Substances
Link
United States
HENDERSON